Jürgen Klammt

Jürgen Klammt

Auto-generated profile, based on publicly available information

Jürgen Klammt

Center for Pediatric Research Leipzig, University Hospital for Children & Adolescents, University of Leipzig, Leipzig, Germany

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2003 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
MAM. Jennifer Abuzzahab
M. Jennifer Abuzzahab
ASAnke Schneider
Anke Schneider
AGAudrey Goddard
Audrey Goddard
Florin GrigorescuFlorin Grigorescu
Florin Grigorescu
CLCorinne Lautier
Corinne Lautier
SCSteven D. Chernausek
Steven D. Chernausek
Approximately 10 percent of infants with intrauterine growth retardation remain small, and the causes of their growth deficits are often unclear. We postulated that mutations in the gene for the insulin-like growth factor I receptor (IGF-IR) might underlie some cases of prenatal and postnatal growth failure. We screened two groups of children for abnormalities in the IGF-IR gene. In one group of 42 patients with unexplained intrauterine growth retardation and subsequent short stature, we used single-strand conformation polymorphism analysis, followed by direct DNA sequencing of any abnormalities found. A second cohort consisted of 50 children with short stature who had elevated circulating IGF-I concentrations. Complete sequencing of the IGF-IR gene was performed with DNA from nine children. We also studied a control group of 43 children with normal birth weights. In the first cohort, we identified one girl who was a compound heterozygote for point mutations in exon 2 of the IGF-IR gene that altered the amino acid sequence to Arg108Gln in one allele and Lys115Asn in the other. Fibroblasts cultured from the patient had decreased IGF-I–receptor function, as compared with that in control fibroblasts. No such mutations were found in the 43 controls. In the second group, we identified one boy with a nonsense mutation (Arg59stop) that reduced the number of IGF-I receptors on fibroblasts. Both children had intrauterine growth retardation and poor postnatal growth. Mutations in the IGF-IR gene that lead to abnormalities in the function or number of IGF-I receptors may also retard intrauterine and subsequent growth in humans.

1 November 2006 in Blood
Verified
Journal Article
Open access
PDF file
KTKatrin Tefs
Katrin Tefs
MGMaria Gueorguieva
Maria Gueorguieva
JKJürgen Klammt
Jürgen Klammt
CACarl M. Allen
Carl M. Allen
DADilek Aktas
Dilek Aktas
VSVolker Schuster
Volker Schuster
Severe type I plasminogen (PLG) deficiency has been causally linked to a rare chronic inflammatory disease of the mucous membranes that may be life threatening. Here we report clinical manifestations, PLG plasma levels, and molecular genetic status of the PLG gene of 50 patients. The most common clinical manifestations among these patients were ligneous conjunctivitis (80%) and ligneous gingivitis (34%), followed by less common manifestations such as ligneous vaginitis (8%), and involvement of the respiratory tract (16%), the ears (14%), or the gastrointestinal tract (2%). Four patients showed congenital occlusive hydrocephalus, 2 with Dandy-Walker malformation of cerebellum. Venous thrombosis was not observed. In all patients, plasma PLG levels were markedly reduced. In 38 patients, distinct mutations in the PLG gene were identified. The most common genetic alteration was a K19E mutation found in 34% of patients. Transient in vitro expression of PLG mutants R134K, delK212, R216H, P285T, P285A, T319_N320insN, and R776H in transfected COS-7 cells revealed significantly impaired secretion and increased degradation of PLG. These results demonstrate impaired secretion of mutant PLG proteins as a common molecular pathomechanism in type I PLG deficiency.

29 May 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
JKJürgen Klammt
Jürgen Klammt
DNDavid Neumann
David Neumann
EGEvelien F. Gevers
Evelien F. Gevers
SAShayne F. Andrew
Shayne F. Andrew
ISI. David Schwartz
I. David Schwartz
VHVivian Hwa
Vivian Hwa
Growth hormone (GH) insensitivity syndrome (GHIS) is a rare clinical condition in which production of insulin-like growth factor 1 is blunted and, consequently, postnatal growth impaired. Autosomal-recessive mutations in signal transducer and activator of transcription (STAT5B), the key signal transducer for GH, cause severe GHIS with additional characteristics of immune and, often fatal, pulmonary complications. Here we report dominant-negative, inactivating STAT5B germline mutations in patients with growth failure, eczema, and elevated IgE but without severe immune and pulmonary problems. These STAT5B missense mutants are robustly tyrosine phosphorylated upon stimulation, but are unable to nuclear localize, or fail to bind canonical STAT5B DNA response elements. Importantly, each variant retains the ability to dimerize with wild-type STAT5B, disrupting the normal transcriptional functions of wild-type STAT5B. We conclude that these STAT5B variants exert dominant-negative effects through distinct pathomechanisms, manifesting in milder clinical GHIS with general sparing of the immune system.

1 February 2011 in Best Practice & Research Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
RPR. Pfäffle
R. Pfäffle
JKJ. Klammt
J. Klammt

1 August 2008 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
JKJürgen Klammt
Jürgen Klammt
RPRoland Pfäffle
Roland Pfäffle
HWHaim Werner
Haim Werner
WKWieland Kiess
Wieland Kiess

1 February 2011 in Best Practice & Research Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
JKJ. Klammt
J. Klammt
WKW. Kiess
W. Kiess
RPR. Pfäffle
R. Pfäffle